| Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma B Zhou, L Guo, B Zhang, S Liu, K Zhang, J Yan, W Zhang, M Yu, Z Chen, ... American journal of cancer research 9 (11), 2442, 2019 | 64 | 2019 |
| Tumor size affects efficacy of adjuvant transarterial chemoembolization in patients with hepatocellular carcinoma and microvascular invasion S Liu, H Li, L Guo, B Zhang, B Zhou, W Zhang, J Zhou, J Fan, Q Ye The Oncologist 24 (4), 513-520, 2019 | 50 | 2019 |
| Integrated analysis of copy number variations and gene expression profiling in hepatocellular carcinoma C Zhou, W Zhang, W Chen, Y Yin, M Atyah, S Liu, L Guo, Y Shi, Q Ye, ... Scientific reports 7 (1), 10570, 2017 | 49 | 2017 |
| Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells L Guo, S Zhang, B Zhang, W Chen, X Li, W Zhang, C Zhou, J Zhang, ... Cell biology and toxicology 32, 263-274, 2016 | 45 | 2016 |
| Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma B Zhou, J Yan, L Guo, B Zhang, S Liu, M Yu, Z Chen, K Zhang, W Zhang, ... Theranostics 10 (14), 6530, 2020 | 37 | 2020 |
| PNOC expressed by B cells in cholangiocarcinoma was survival related and LAIR2 could be a T cell exhaustion biomarker in tumor microenvironment: characterization of immune … Z Chen, M Yu, J Yan, L Guo, B Zhang, S Liu, J Lei, W Zhang, B Zhou, ... Frontiers in immunology 12, 647209, 2021 | 31 | 2021 |
| PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy M Yu, Z Chen, Q Zhou, B Zhang, J Huang, L Jin, B Zhou, S Liu, J Yan, X Li, ... Journal of Hepatology 77 (1), 140-151, 2022 | 22 | 2022 |
| GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma J Yan, B Zhou, L Guo, Z Chen, B Zhang, S Liu, W Zhang, M Yu, Y Xu, ... American journal of cancer research 10 (11), 3705, 2020 | 22 | 2020 |
| Tumor derived SIGLEC family genes may play roles in tumor genesis, progression, and immune microenvironment regulation Z Chen, M Yu, L Guo, B Zhang, S Liu, W Zhang, B Zhou, J Yan, Q Ma, ... Frontiers in Oncology 10, 586820, 2020 | 18 | 2020 |
| Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection C Zhou, W Chen, J Sun, M Atyah, Y Yin, W Zhang, L Guo, Q Ye, Q Dong, ... Cancer medicine 7 (7), 3031-3043, 2018 | 18 | 2018 |
| Clinical analysis of gastroenteropancreatic neuroendocrine tumor with liver metastasis, compared with primary hepatic neuroendocrine tumor YH Shen, S Chen, WT Zhang, Y Ji, L Yu, HC Sun, SJ Qiu, N Ren, J Zhou Journal of Cancer Research and Therapeutics 10 (Suppl 4), C276-C280, 2014 | 16 | 2014 |
| Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro Z Chen, S Liu, P Xie, B Zhang, M Yu, J Yan, L Jin, W Zhang, B Zhou, X Li, ... Biochemical and Biophysical Research Communications 605, 82-89, 2022 | 13 | 2022 |
| Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma W Chen, C Zhou, W Zhang, M Atyah, Y Yin, L Guo, W Tang, Q Dong, Q Ye, ... Journal of Cancer 9 (7), 1239, 2018 | 7 | 2018 |
| High serum gamma-glutamyl transpeptidase concentration associates with poor postoperative prognosis of patients with Hepatitis B virus-associated intrahepatic cholangiocarcinoma B Zhang, S Liu, B Zhou, L Guo, H Li, J Yan, W Zhang, M Yu, Z Chen, Y Xu, ... Annals of Translational Medicine 9 (1), 2021 | 2 | 2021 |
| Association of intrinsic pathways with altered tumor immune infiltration in hepatocellular carcinoma: New targets for combining immune therapy Z Chen, M Yu, J Yan, B Zhou, W Zhang, L Guo, B Zhang, S Liu, L Jin, ... Clinical and Translational Medicine 10 (7), 2020 | 1 | 2020 |
